Childhood interstitial lung disease (chILD) is a heterogeneous group of diseases with various clinical and imaging findings. The incidence and prevalence have increased in recent years, probably due to better comprehension of these rare diseases and increased awareness among physicians. chILDs present with nonspecific pulmonary symptoms, such as tachypnea, hypoxemia, cough, rales, and failure to thrive. Unnecessary invasive procedures can be avoided if specific mutations are detected through genetic examinations or if typical imaging patterns are recognized on computed tomography. Disease knowledge and targeted therapies are improving through international collaboration. Pulmonary involvement in systemic diseases is not uncommon. Pulmonary involvement may be the first finding in connective tissue diseases. This review aims to present a systematic patient-targeted approach to the diagnosis of chILD.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- pulmonary hypertension
- rheumatoid arthritis
- computed tomography
- idiopathic pulmonary fibrosis
- high resolution
- risk factors
- mental health
- primary care
- healthcare
- magnetic resonance imaging
- young adults
- positron emission tomography
- case report
- early life
- gene expression
- copy number
- magnetic resonance
- physical activity
- fluorescence imaging
- drug induced